Suppr超能文献

儿童粪便钙卫蛋白参考范围:一项英国研究。

Paediatric reference ranges for faecal calprotectin: a UK study.

作者信息

Davidson Fiona, Lock Robert J

机构信息

1 Clinical Biochemistry, North Bristol NHS Trust, Bristol, UK.

2 Immunology and Immunogenetics, North Bristol NHS Trust Bristol, UK.

出版信息

Ann Clin Biochem. 2017 Mar;54(2):214-218. doi: 10.1177/0004563216639335. Epub 2016 Sep 30.

Abstract

Background Faecal calprotectin has been shown to be a useful non-invasive marker for the diagnosis and monitoring of inflammatory bowel disease in children and adults. Although there are well-established reference ranges for the diagnosis of inflammatory bowel disease in adults, these have been less well studied in children. The objective was to establish reference ranges in our local population. Method All faecal calprotectin results from 2011 to 2014 were retrospectively collated and grouped according to patient age. Probability plots were used to determine expected upper limit of normal for each age group, and Mann-Whitney test was used to determine statistical difference between groups. Results Upper limit of normal for age groups 1-3.9 years, 4-17.9 years and 18 years plus were 77, 62 and 61  µg/g, respectively. There was a significant difference ( P = 0.0013) between the median calprotectin concentration for the age group 1-3.9 years ( n = 87) and 4-17.9 years ( n = 636) and between the age group 1-3.9 years and 18 years plus ( n = 7953, P = 0.0001), but there was no significant difference between the age groups 4-17.9 years and 18 years plus ( P = 0.4206). Conclusions In our local population, faecal calprotectin varies with age. Children aged 1-3.9 years had higher concentrations of faecal calprotectin than adults, but there was no significant difference in faecal calprotectin between older children and adults. This is in agreement with other published studies; however, the faecal calprotectin upper limit of normal calculated for children aged 1-3.9 years was lower than has been observed elsewhere.

摘要

背景

粪便钙卫蛋白已被证明是诊断和监测儿童及成人炎症性肠病的一种有用的非侵入性标志物。尽管在成人炎症性肠病诊断方面已有公认的参考范围,但在儿童中对此研究较少。目的是确定我们当地人群的参考范围。方法:回顾性整理2011年至2014年所有粪便钙卫蛋白检测结果,并根据患者年龄进行分组。使用概率图确定各年龄组正常上限,采用曼-惠特尼检验确定组间统计学差异。结果:1 - 3.9岁、4 - 17.9岁和18岁及以上年龄组的正常上限分别为77、62和61 µg/g。1 - 3.9岁年龄组(n = 87)与4 - 17.9岁年龄组(n = 636)之间以及1 - 3.9岁年龄组与18岁及以上年龄组(n = 7953,P = 0.0001)之间粪便钙卫蛋白浓度中位数存在显著差异(P = 0.0013),但4 - 17.9岁年龄组与18岁及以上年龄组之间无显著差异(P = 0.4206)。结论:在我们当地人群中,粪便钙卫蛋白随年龄而异。1 - 3.9岁儿童的粪便钙卫蛋白浓度高于成人,但大龄儿童与成人之间粪便钙卫蛋白无显著差异。这与其他已发表研究一致;然而,计算得出的1 - 3.9岁儿童粪便钙卫蛋白正常上限低于其他地方观察到的数值。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验